Literature DB >> 12956784

Postoperative confusion assessed with the Short Portable Mental Status Questionnaire.

Amirarsalan Eissa1, Marie J Andrew, Robert A Baker.   

Abstract

BACKGROUND: Confusion is a common occurrence after cardiac surgery. However, there is great variability in the reported incidence of confusion in patients following cardiac surgery, mainly due to the diagnostic methods and instruments employed in assessing confusion.
METHODS: Forty-eight cardiac surgery patients were assessed for postoperative confusion by a non-structured physician interview, and by the short portable mental status questionnaire (SPMSQ) administered by a medical student.
RESULTS: The non-structured ward interviews detected confusion in one of the 48 patients (2%), whereas the SPMSQ diagnosed confusion in 15 of the 48 patients (31%).
CONCLUSION: Unlike a subjective ward interview, the SPMSQ is a brief and objective diagnostic tool that can be used to measure accurately both the presence and severity of confusion in postoperative cardiac surgery patients.

Entities:  

Mesh:

Year:  2003        PMID: 12956784     DOI: 10.1046/j.1445-2197.2003.02740.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  3 in total

1.  [Confusion Assessment Method for the Intensive Care Unit (CAM-ICU): diagnosis of postoperative delirium in cardiac surgery].

Authors:  M Klugkist; B Sedemund-Adib; C Schmidtke; P Schmucker; H H Sievers; M Hüppe
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

2.  The role of depression and anxiety symptoms in hospital readmissions after cardiac surgery.

Authors:  Phillip J Tully; Robert A Baker; Deborah Turnbull; Helen Winefield
Journal:  J Behav Med       Date:  2008-04-09

3.  The importance of depression and alcohol use in coronary artery bypass graft surgery patients: risk factors for delirium and poorer quality of life.

Authors:  Joanne M Humphreys; Linley A Denson; Robert A Baker; Phillip J Tully
Journal:  J Geriatr Cardiol       Date:  2016-01       Impact factor: 3.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.